Evidence map›Paper›PMID 33507884›Full record

ArticleJCI insight2021

The Na+, K+-ATPase β1 subunit regulates epithelial tight junctions via MRCKα.

Haiqing Bai, Rui Zhou, Michael Barravecchia, Rosemary Norman, Alan Friedman, Deborah Yu, Xin Lin, Jennifer L Young, David A Dean

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Evaluation ofMolecules (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Haiqing BaiDepartment of Pediatrics and.
Rui ZhouDepartment of Pediatrics and.
Michael BarravecchiaDepartment of Pediatrics and.
Rosemary NormanDepartment of Pediatrics and.
Alan FriedmanDepartment of Pediatrics and.
Deborah YuDepartment of Pediatrics and.
Xin LinDepartment of Pediatrics and.
Jennifer L YoungDepartment of Pediatrics and.
David A DeanDepartment of Pediatrics and.
University at Buffalo, State University of New York · USUniversity of Rochester · US

Funding

Development of a gene therapy approach to treat acute lung injury using a preclinical, large animal modelR01HL131143 · NHLBI · UNIVERSITY OF ROCHESTER · PI DEAN, DAVID A · 2016 to 2019
$3.0M
A multimodal delivery and treatment approach for Acute Lung InjuryR01HL148825 · NHLBI · UNIVERSITY OF ROCHESTER · PI DEAN, DAVID A · 2020 to 2023
$2.3M
Cell-specific gene delivery methods for expression and silencing in the lungR01HL120521 · NHLBI · UNIVERSITY OF ROCHESTER · PI DEAN, DAVID A · 2014 to 2017
$1.5M
NHLBI NIH HHS R01 HL120521NHLBI NIH HHS R01 HL131143NHLBI NIH HHS R01 HL148825
6 · The paper itself

Abstract

An intact lung epithelial barrier is essential for lung homeostasis. The Na+, K+-ATPase (NKA), primarily serving as an ion transporter, also regulates epithelial barrier function via modulation of tight junctions. However, the underlying mechanism is not well understood. Here, we show that overexpression of the NKA β1 subunit upregulates the expression of tight junction proteins, leading to increased alveolar epithelial barrier function by an ion transport-independent mechanism. Using IP and mass spectrometry, we identified a number of unknown protein interactions of the β1 subunit, including a top candidate, myotonic dystrophy kinase-related cdc42-binding kinase α (MRCKα), which is a protein kinase known to regulate peripheral actin formation. Using a doxycycline-inducible gene expression system, we demonstrated that MRCKα and its downstream activation of myosin light chain is required for the regulation of alveolar barrier function by the NKA β1 subunit. Importantly, MRCKα is expressed in both human airways and alveoli and has reduced expression in patients with acute respiratory distress syndrome (ARDS), a lung illness that can be caused by multiple direct and indirect insults, including the infection of influenza virus and SARS-CoV-2. Our results have elucidated a potentially novel mechanism by which NKA regulates epithelial tight junctions and have identified potential drug targets for treating ARDS and other pulmonary diseases that are caused by barrier dysfunction.

Indexed as

Alveolar Epithelial CellsAnimalsHEK293 CellsHumansMyotonin-Protein KinasePrimary Cell CultureRatsRecombinant ProteinsRespiratory Distress SyndromeSARS-CoV-2Sodium-Potassium-Exchanging ATPaseTight JunctionsATP1B1 protein, humanCDC42BPA protein, humanMyotonin-Protein KinaseRecombinant ProteinsSodium-Potassium-Exchanging ATPaseCell BiologyGene therapyPulmonologyTight junctions

Identifiers

PMID33507884
PMCPMC7934944
OpenAlexW3122769209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.